Does Medicare cover migraine prevention treatment? This guide explains Parts A, B, D, Medicare Advantage, CGRP access challenges, and where to get real help.
If you are on Medicare and your neurologist has recommended a preventive migraine treatment, the first question that follows is almost always whether Medicare covers migraine prevention treatment and what it will actually cost you. The answer depends on which part of Medicare you have, what type of medication your doctor prescribes, and how your specific plan's formulary is structured. None of those factors are fixed across all beneficiaries, and the details matter a great deal, especially for newer CGRP biologic treatments where out-of-pocket costs without coverage can be substantial.
This guide covers how Medicare is organized, which parts are relevant to migraine treatment, why CGRP biologics present particular challenges for Medicare patients, and where to get accurate, unbiased help sorting through your options.
Medicare is divided into parts, each covering a different category of care. Understanding which part applies to your migraine treatment determines everything about how costs and approvals work.
| Medicare Part | What It Covers | Relevant to Migraine? |
|---|---|---|
| Part A | Hospital inpatient care, skilled nursing, hospice | Rarely, only for inpatient stays |
| Part B | Doctor visits, outpatient services, some injected drugs given in a clinical setting | Yes, for some injected preventive treatments |
| Part D | Prescription drugs you pick up at a pharmacy | Yes, for most oral preventive medications |
| Medicare Advantage (Part C) | Bundled private plan replacing Original Medicare, usually includes drug coverage | Yes, but plan rules vary significantly |
Most migraine prevention happens outside a hospital, so Part A is rarely involved. The relevant coverage question is whether your treatment lands under Part B or Part D, and that depends on how the medication is administered.
For migraine prevention specifically, the Part B versus Part D split comes down to how the drug is administered.
Part D covers most oral preventive medications. This includes both older generic preventives and oral CGRP receptor antagonists used for prevention. These are filled at a pharmacy and covered under a Part D prescription drug plan, either as a standalone plan with Original Medicare or bundled into a Medicare Advantage plan.
Part B covers certain drugs administered by a clinician in an office or clinical setting rather than self-administered at home. Some injected CGRP preventive treatments may qualify under Part B depending on how they are administered and how your physician's office bills. When a drug qualifies under Part B, cost-sharing works differently than under Part D.
The distinction is not always intuitive. Two treatments in the same drug class can fall under different parts depending on administration method, which is why confirming with your plan before starting treatment is worth the call. For a broader look at CGRP treatment cost across insurance types, that guide covers the full landscape.
Coverage under both Part B and Part D typically requires prior authorization for CGRP preventive medications. Your prescriber submits documentation establishing medical necessity before the plan agrees to cover the cost.
For most Medicare plans, that documentation includes:
The prior authorization process for CGRP medications under Medicare works similarly to commercial insurance in structure, but formulary rules and tier placements vary substantially by plan. A medication that is on a preferred tier in one Part D plan may be on a specialty tier in another, with dramatically different cost-sharing. See CGRP prior authorization and renewal for a detailed walkthrough of what the documentation process requires.
Understanding what your monthly migraine day count actually is before your prescriber submits a PA request gives them the most accurate baseline to document.
This is where Medicare coverage for CGRP biologics gets genuinely harder than commercial insurance.
With commercial insurance, many CGRP medication manufacturers offer copay assistance cards or patient assistance programs that can reduce a patient's out-of-pocket cost substantially, sometimes to a few dollars per month. These programs are widely used and make CGRP treatment financially accessible for many commercially insured patients.
Medicare beneficiaries cannot use those programs. Federal law prohibits pharmaceutical manufacturers from offering copay assistance to people enrolled in government insurance programs, including Medicare. The intent is to prevent manufacturers from steering patients toward expensive drugs by masking the true cost. The practical effect is that Medicare patients face their plan's standard cost-sharing without the offset that commercial insurance patients often rely on.
What this means in practice: the out-of-pocket cost for a CGRP preventive under Medicare depends entirely on your plan's formulary placement and cost-sharing tier, without any manufacturer subsidy reducing that amount. This is a significant distinction to understand before comparing your situation to what a friend or family member with employer insurance might pay.
Medicare Advantage (Part C) plans are private plans approved by Medicare that bundle Part A, Part B, and usually Part D coverage. They are required to cover at least the same benefits as Original Medicare, but they operate under their own networks, formularies, and rules.
For migraine prevention, this creates meaningful variation:
Original Medicare with a standalone Part D plan follows CMS formulary standards but also varies between Part D plans in what is covered and at what tier.
The implication: comparing plans during open enrollment is worth doing carefully if migraine prevention is part of your ongoing care. A comparison focused on your specific medications can make a substantial difference in annual costs.
The Extra Help program, formally called the Low Income Subsidy, provides financial assistance to Medicare beneficiaries with limited income and resources for Part D costs. Eligible beneficiaries pay reduced or no premiums, deductibles, and copays for Part D prescription drugs, including preventive medications.
If cost is a barrier to accessing migraine prevention treatment under Medicare, Extra Help is worth investigating before assuming treatment is out of reach. Eligibility is income and asset-based, with thresholds set annually by the Social Security Administration. You can apply through Social Security or get help applying through your state's SHIP program.
Two free resources are worth knowing and actually using:
Medicare.gov offers plan comparison tools that let you enter your specific medications and see what each available plan in your area covers, at what tier, and at what estimated cost. It is the most direct way to compare Part D and Medicare Advantage plans for your situation.
State Health Insurance Assistance Program (SHIP) provides free, one-on-one counseling from trained volunteers who help Medicare beneficiaries understand coverage, compare plans, and navigate appeals. SHIP counselors are not affiliated with any insurance company, so the guidance is unbiased. Every state has a SHIP program, and appointments are free. If you are trying to understand your options for CGRP coverage specifically, a SHIP counselor can help you read your plan's formulary and identify your actual cost-sharing exposure.
For questions about Extra Help eligibility or about your rights during the appeals process for a denied prior authorization, both resources are well-equipped to help.
A denial is not the end of the road. Medicare beneficiaries have formal appeal rights, and denials based on formulary issues, step therapy requirements, or insufficient documentation can often be reversed with the right evidence.
The appeals process requires your prescriber to submit additional clinical documentation. The strength of that submission depends on the quality of the clinical record: documented migraine frequency over time, evidence of prior treatment attempts and their outcomes, and functional impact data. Your prescriber can also request an expedited review in cases where a delay would seriously harm your health.
Knowing your episodic vs. chronic migraine classification and having documented migraine day counts available makes it easier for your prescriber to build a complete, specific submission. Plans vary in their appeals timelines and criteria, so verifying the specific process with your plan is the right first step after a denial.
Medicare plans reviewing prior authorization requests or appeals are looking for clinical evidence, and the most useful clinical evidence is longitudinal data showing what your migraine burden actually looks like over time.
A consistent daily log of migraine days, severity, and medication use gives your prescriber specific numbers to document: your baseline MMD before treatment, your current MMD on treatment, and the degree of functional improvement. You can use the migraine reduction calculator to quantify your treatment response as a percentage reduction in migraine days, a format that maps directly to what reviewers are looking for when evaluating whether a treatment is producing meaningful clinical benefit.
The CGRP renewal report available through Migraine Tracker: CGRP Log formats that data into a structured one-page summary your neurologist can attach directly to a prior authorization or renewal submission, turning your daily logs into the documentation that keeps coverage intact. Medicare's coverage rules shift at the plan level and change year to year. What stays constant is that patients with the clearest, most organized documentation of their migraine history and treatment response are the ones with the strongest position when coverage decisions are being made.
Educational, not medical advice. Migraine Tracker: CGRP Log is a personal tracking tool, not a medical device. It does not diagnose, treat, or provide medical advice. Always talk to your clinician.
Medicare can cover CGRP preventive treatments, but coverage depends on which part of Medicare you have and the specific plan's formulary. Oral CGRP medications typically fall under Part D, while some injected treatments may qualify under Part B. Coverage rules vary by plan and year, so verify directly with Medicare.gov or your plan.
Learn what documentation is needed for migraine prior authorization, from diagnosis records and step therapy notes to headache diaries and functional impairment scores.
CGRP treatment costs are among the highest in migraine care. This plain-language guide explains why, how insurance works, and how documentation protects your access.
Learn how to fight migraine treatment insurance denial step by step: decode your denial letter, build a strong appeal packet, and know when to escalate.
